Crohn's Disease (Bentz et al.)

🟡 Moderate clinical evidence (controlled clinical trial)

Study at a glance

  • Participants: 40 adults
  • Condition: Crohn's disease
  • Study type: Double-blind, cross-over dietary intervention
  • Duration: Two 6-week diet phases

What was done

Participants with Crohn's disease took a food-specific IgG blood test. They then followed two different diets:

  • A diet removing foods identified by the test
  • A control (sham) diet removing unrelated foods

Each participant completed both diets at different times, without knowing which one they were following.

What improved

When participants followed the IgG-guided diet:

  • Symptoms improved compared to the control (sham) diet, including reductions in abdominal pain and bowel-related symptoms
  • Participants reported better overall wellbeing during the IgG-guided phase

In practical terms, this means participants experienced fewer and less severe digestive symptoms when avoiding foods identified by the test.

Key takeaway

Avoiding foods identified by IgG testing was associated with reduced digestive symptoms and improved wellbeing in people with Crohn's disease.

What this means

This study suggests that food-specific IgG responses may contribute to symptom activity in Crohn's disease. Identifying and removing reactive foods may help reduce symptom burden alongside standard care.

🟡 Evidence strength

Moderate clinical evidence (controlled cross-over study)

Full citation

Bentz et al. 2010 Crohn's IgG trial

Bentz S, Hausmann M, Piberger H, et al.
Clinical relevance of IgG antibodies against food antigens in Crohn's disease: a double-blind cross-over diet intervention study.
Digestion. 2010;81(4):252–264.

Weblink:
View study


Explore other studies

Supply Life

Unlock your full potential today

Get your easy to use food intolerance test today

Discover Products

Order Now
Supply Life

Unlock your full potential today

Get your easy to use food intolerance test today

Discover Products

Order Now